NEW YORK (GenomeWeb News) – Image-analysis company Syngene said on Friday that it has tapped Varelas to distribute its products in Greece.
 
Under the agreement, Athens-based in vitro diagnostic distributor Varelas will market Syngene’s1D gel documentation systems, including its U:Genius and the G:Box image-analysis systems, as well as its Dyversity and Dymension systems for 2D gel analysis.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.